Biocon Limited
BIOCON
株式のランク
#3399
Biocon Limited functions as a biopharmaceutical firm, engaged in the production... Biocon Limited functions as a biopharmaceutical firm, engaged in the production of pharmaceutical, medicinal chemical, and plant-derived products. Its business activities are organized into distinct segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company dedicates its efforts to crucial therapeutic domains, including diabetes, oncology, immunology, ophthalmology, and bone health disorders. Furthermore, Biocon provides comprehensive services encompassing the discovery, development, and manufacturing of both small and large molecules. With a wide international presence, it caters to customers in roughly 120 nations. Headquartered in Bengaluru, India, Biocon Limited commenced operations in 1978.
株価
$3.75
最終同期: 2026-10-19
時価総額
$5.13B
変化（1日）
-2.30%
変化（1年）
-9.49%
国
IN
取引 Biocon Limited (BIOCON)
カテゴリー
Healthcare
Biocon Limited（BIOCON）の発行済株式数
June 2026 時点の発行済株式数 1.62B
Biocon Limited の最新の財務報告および株価によると、現在の発行済株式数は 1.62B です。March 2024 の終わりには、同社は 1.20B 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Biocon Limited（BIOCON）の発行済株式数の履歴（2004 ～ 2026）
各年末時点の発行済株式数
| 年 | 発行済株式数 | 変化 |
|---|---|---|
| 2026 (TTM) | 1.62B | 35.41% |
| 2025 | 1.20B | 0.15% |
| 2024 | 1.20B | 0.24% |
| 2023 | 1.19B | 0.17% |
| 2022 | 1.19B | 0.33% |
| 2021 | 1.19B | 0.25% |
| 2020 | 1.18B | 0.07% |
| 2019 | 1.18B | 0.29% |
| 2018 | 1.18B | 0.18% |
| 2017 | 1.18B | 0.00% |
| 2016 | 1.18B | -1.85% |
| 2015 | 1.20B | 1.92% |
| 2014 | 1.18B | 0.21% |
| 2013 | 1.17B | -0.04% |
| 2012 | 1.18B | 0.19% |
| 2011 | 1.17B | 0.54% |
| 2010 | 1.17B | 0.80% |
| 2009 | 1.16B | -0.13% |
| 2008 | 1.16B | -0.05% |
| 2007 | 1.16B | 1.13% |
| 2006 | 1.15B | 1.03% |
| 2005 | 1.14B | 11.70% |
| 2004 | 1.02B | 0.00% |
類似企業や競合他社の発行済株式数
| 企業 | 発行済株式数 | 差 | 国 |
|---|---|---|---|
| 253.90M | -84.34% |
US
|
|
| 396.00M | -75.58% |
US
|
|
| 478.91M | -70.47% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | -96.17% |
NL
|
